Back
Permian Resources Vs. Monopar Therapeutics Industry Stock Comparison
Sell
38
PR
Permian Resources
Last Price:
$14.52
Seasonality Move:
-9.16%
Buy
63
MNPR
Monopar Therapeutics
Last Price:
$42.88
Seasonality Move:
-18.4%
Sell
38
Permian Resources (PR)
is a Sell
Is Permian Resources a Buy, Sell or Hold?
-
The current Permian Resources [PR] share price is $14.30. The Score for PR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
PR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $44.12. The Score for MNPR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PR Stock Price Chart
What is Permian Resources's stock price today?
-
The Permian Resources share price today is $14.30Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PR is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $44.12The current trend is moderately bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
PR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 42.63 | Sell |
| Chaikin Money Flow: | 3143896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.43 - 15.55) | Sell |
| Bollinger Bands (100): | (13.89 - 15.31) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.61 | Buy |
| Relative Strength Index (14 RSI): | 56.19 | Buy |
| Chaikin Money Flow: | 28636 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.93 - 48.45) | Buy |
| Bollinger Bands (100): | (9.46 - 35.56) | Buy |
PR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.45 | Sell |
| 20-day SMA: | 14.81 | Sell |
| 50-day SMA: | 14.73 | Sell |
| 200-day SMA: | 14.95 | Sell |
| 8-day EMA: | 14.44 | Sell |
| 20-day EMA: | 14.67 | Sell |
| 50-day EMA: | 14.75 | Sell |
| 200-day EMA: | 14.7 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.65 | Sell |
| 20-day SMA: | 43.41 | Buy |
| 50-day SMA: | 32.27 | Buy |
| 200-day SMA: | 12.93 | Buy |
| 8-day EMA: | 45.99 | Sell |
| 20-day EMA: | 42.65 | Buy |
| 50-day EMA: | 34.24 | Buy |
| 200-day EMA: | 17.72 | Buy |
Permian Resources Earnings Growth & PR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.09 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Permian Resources Technical Analysis
| Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||